- Home
- AVT vs ACLX Comparison
AVT vs ACLX Comparison
Compare AVT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVT
- ACLX
- Stock Information
- Founded
- AVT 1921
- ACLX 2015
- Country
- AVT United States
- ACLX United States
- Employees
- AVT N/A
- ACLX N/A
- Industry
- AVT Electronic Components
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- AVT Technology
- ACLX Health Care
- Exchange
- AVT Nasdaq
- ACLX Nasdaq
- Market Cap
- AVT 4.3B
- ACLX 4.1B
- IPO Year
- AVT N/A
- ACLX 2022
- Fundamental
- Price
- AVT $53.45
- ACLX $76.19
- Analyst Decision
- AVT Sell
- ACLX Strong Buy
- Analyst Count
- AVT 3
- ACLX 13
- Target Price
- AVT $49.00
- ACLX $114.75
- AVG Volume (30 Days)
- AVT 1.1M
- ACLX 551.2K
- Earning Date
- AVT 10-29-2025
- ACLX 11-06-2025
- Dividend Yield
- AVT 2.47%
- ACLX N/A
- EPS Growth
- AVT N/A
- ACLX N/A
- EPS
- AVT 2.75
- ACLX N/A
- Revenue
- AVT $22,200,754,000.00
- ACLX $56,979,000.00
- Revenue This Year
- AVT $5.51
- ACLX N/A
- Revenue Next Year
- AVT $6.01
- ACLX $174.18
- P/E Ratio
- AVT $19.44
- ACLX N/A
- Revenue Growth
- AVT N/A
- ACLX N/A
- 52 Week Low
- AVT $39.22
- ACLX $47.86
- 52 Week High
- AVT $59.24
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- AVT 48.91
- ACLX 63.27
- Support Level
- AVT $52.51
- ACLX $70.11
- Resistance Level
- AVT $54.47
- ACLX $73.10
- Average True Range (ATR)
- AVT 1.00
- ACLX 2.57
- MACD
- AVT -0.03
- ACLX 0.55
- Stochastic Oscillator
- AVT 43.53
- ACLX 79.16
About AVT Avnet Inc.
Avnet Inc is a global distributor of electronic components, connecting suppliers of semiconductors and other components to a base of 2.1 million small- and mid-sized customers in 140 countries. Avnet is the third largest semiconductor distributor in the world, and the largest for European chip distribution. Avnet services all levels of electronics design and development, servicing engineers with design tools, test kits, and services alongside its high-volume distribution for final designs.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.